U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280221) titled 'WEgovy Real World Assessment of Weight Loss in Korea' on Nov. 24.
Brief Summary: This study is to investigate the effectiveness and safety of Wegovy (semaglutide) in Korean patients living with obesity in routine clinical practice. The purpose of this study is to investigate the change in body weight and other clinical characteristics related to body weight in patients living with obesity. Participants will be treated with Wegovy (semaglutide) as prescribed by their doctor, in accordance with normal clinical practice. The study will last for about 52 weeks.
Study Start Date: Nov. 10
Study Type: OBSERVATIONAL
Condition:
Obesity
...